» Articles » PMID: 20038536

Associations Between Mucosal Innate and Adaptive Immune Responses and Resolution of Diarrheal Pathogen Infections

Overview
Journal Infect Immun
Date 2009 Dec 30
PMID 20038536
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

The identification of immune response mechanisms that contribute to the control of diarrheal disease in developing countries remains an important priority. We addressed the role of fecal chemokines and cytokines in the resolution of diarrheal Escherichia coli and Giardia lamblia infections. Stools collected from 127 Mexican children 5 to 15 months of age enrolled in a randomized, double-blind, placebo-controlled, vitamin A supplementation trial were screened for enteropathogenic Escherichia coli (EPEC), enterotoxigenic E. coli (ETEC), and Giardia lamblia. Fecal concentrations of tumor necrosis factor alpha (TNF-alpha), monocyte chemoattractant protein-1 (MCP-1), interleukin-4 (IL-4), IL-5, IL-6, IL-8, IL-10, and interferon-gamma (IFN-gamma) were determined. Hazard models incorporating cytokine variables were fit to durations of asymptomatic and symptomatic pathogen infections, controlling for treatment group. Increased levels of TNF-alpha and IL-6 were associated with decreased durations of EPEC infection and increased ETEC durations. Increased IL-4 and IFN-gamma levels were associated with decreased and increased durations, respectively, of both EPEC and ETEC infections. Increased IL-10 levels were associated with increased and decreased durations of asymptomatic and symptomatic EPEC infections, respectively, and increased durations of both asymptomatic and symptomatic ETEC infections. Increased levels of MCP-1, IFN-gamma, IL-4, and IL-5 were associated with increased G. lamblia infection duration, while increased IL-8 levels were associated with decreased durations. Differences in proinflammatory and Treg cytokine levels are associated with differences in the resolution of inflammatory and noninflammatory pathogen infections.

Citing Articles

Validation of a Human Challenge Model Using an LT-Expressing Enterotoxigenic Strain (LSN03-016011) and Characterization of Potential Amelioration of Disease by an Investigational Oral Vaccine Candidate (VLA1701).

Talaat K, Porter C, Chakraborty S, Feijoo B, Brubaker J, Adjoodani B Microorganisms. 2024; 12(4).

PMID: 38674674 PMC: 11051778. DOI: 10.3390/microorganisms12040727.


Respiratory allergy symptoms and cytokine profiles in the presence of anti-Ascaris antibody in Giardia lamblia-infected children.

Fontenele A, de Oliveira Nobrega C, do Nascimento W, Santos P, Lorena V, Peixoto D Parasitol Res. 2023; 122(12):3147-3158.

PMID: 37875615 DOI: 10.1007/s00436-023-08005-z.


Role of mucus-bacteria interactions in Enterotoxigenic Escherichia coli (ETEC) H10407 virulence and interplay with human microbiome.

Sauvaitre T, Van Landuyt J, Durif C, Roussel C, Sivignon A, Chalancon S NPJ Biofilms Microbiomes. 2022; 8(1):86.

PMID: 36266277 PMC: 9584927. DOI: 10.1038/s41522-022-00344-6.


Mucosal Immune Profiles Associated with Diarrheal Disease Severity in - and Enteropathogenic Escherichia coli-Infected Children Enrolled in the Global Enteric Multicenter Study.

Buskirk A, Ndungo E, Shimanovich A, Lam D, Blackwelder W, Ikumapayi U mBio. 2022; 13(4):e0053822.

PMID: 35924851 PMC: 9426439. DOI: 10.1128/mbio.00538-22.


Dynamic monitoring and a clinical correlation analysis of the serum vitamin A, D, and E levels in children with recurrent respiratory tract infections.

Sun M, Yan Z, Sun R, Tian W, Yi W, Zhang J Am J Transl Res. 2022; 14(5):3533-3538.

PMID: 35702083 PMC: 9185048.


References
1.
Lebeis S, Sherman M, Kalman D . Protective and destructive innate immune responses to enteropathogenic Escherichia coli and related A/E pathogens. Future Microbiol. 2008; 3(3):315-28. DOI: 10.2217/17460913.3.3.315. View

2.
Flores J, DuPont H, Lee S, Belkind-Gerson J, Paredes M, Mohamed J . Influence of host interleukin-10 polymorphisms on development of traveler's diarrhea due to heat-labile enterotoxin-producing Escherichia coli in travelers from the United States who are visiting Mexico. Clin Vaccine Immunol. 2008; 15(8):1194-8. PMC: 2519301. DOI: 10.1128/CVI.00070-08. View

3.
Simmons C, Goncalves N, Ghaem-Maghami M, Bajaj-Elliott M, Clare S, Neves B . Impaired resistance and enhanced pathology during infection with a noninvasive, attaching-effacing enteric bacterial pathogen, Citrobacter rodentium, in mice lacking IL-12 or IFN-gamma. J Immunol. 2002; 168(4):1804-12. DOI: 10.4049/jimmunol.168.4.1804. View

4.
Jun S, Gilmore W, Callis G, Rynda A, Haddad A, Pascual D . A live diarrheal vaccine imprints a Th2 cell bias and acts as an anti-inflammatory vaccine. J Immunol. 2005; 175(10):6733-40. DOI: 10.4049/jimmunol.175.10.6733. View

5.
Langford T, Housley M, Boes M, Chen J, Kagnoff M, Gillin F . Central importance of immunoglobulin A in host defense against Giardia spp. Infect Immun. 2001; 70(1):11-8. PMC: 127595. DOI: 10.1128/IAI.70.1.11-18.2002. View